mitomycin has been researched along with aminolevulinic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Allman, R; Datta, SN; Loh, C; Mason, M; Matthews, PN | 1 |
| Allman, R; Datta, SN; French, AJ; Matthews, PN | 1 |
| Allman, R; Datta, SN; French, AJ; Mason, MD; Matthews, PN; Skyrme, RJ | 1 |
| Senior, K | 1 |
| Bosch, JL; Draga, RO; Grimbergen, MC; Jonges, TN; Kok, ET; van Swol, CF | 1 |
| Chandra, A; Chatterton, K; Khan, MS; O'Brien, T; Ray, E; Thomas, K | 1 |
| Bastide, C; Bay, JO; Bruyere, F; Guy, L; Karsenty, G; Mahammedi, H | 1 |
| Lotan, Y | 1 |
| Hanazaki, K; Inoue, K; Ishii, T; Ishizuka, M; Karashima, T; Kawada, C; Nakayama, T; Namikawa, T; Nozawa, N; Ogura, SI; Yamamoto, S | 1 |
| Breyer, J; Burger, M; Cordes, J; Fritsche, HM; Gierth, M; Karl, A; Mayr, R; Sommerhuber, A; Stenzl, A; von Schmeling, IK; Zaak, D; Zeman, F; Zierer, T | 1 |
1 review(s) available for mitomycin and aminolevulinic acid
| Article | Year |
|---|---|
[Medical treatment of bladder carcinoma].
Topics: Aminolevulinic Acid; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Cisplatin; Cystoscopy; Deoxycytidine; Doxorubicin; Fluorescence; Gemcitabine; Humans; Methotrexate; Mitomycin; Photosensitizing Agents; Urinary Bladder Neoplasms; Vinblastine | 2013 |
4 trial(s) available for mitomycin and aminolevulinic acid
| Article | Year |
|---|---|
A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.
Topics: Aged; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Urinary Bladder Neoplasms | 2005 |
Photodynamic therapy for bladder cancer.
Topics: Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Humans; Mitomycin; Neoplasm Recurrence, Local; Photochemotherapy; Urinary Bladder Neoplasms | 2005 |
Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasi
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antibiotics, Antineoplastic; Cystoscopy; Female; Fluorescence; Humans; Light; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms | 2013 |
The HELENA study: Hexvix
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma; Chemotherapy, Adjuvant; Cystectomy; Cystoscopy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mitomycin; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Urinary Bladder Neoplasms | 2021 |
6 other study(ies) available for mitomycin and aminolevulinic acid
| Article | Year |
|---|---|
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
Topics: Aminolevulinic Acid; Carcinoma, Transitional Cell; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Mitomycin; Photochemotherapy; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1997 |
Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model.
Topics: Aminolevulinic Acid; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Drug Interactions; Drug Resistance, Neoplasm; Humans; Mitochondria; Mitomycin; Photochemotherapy; Photosensitizing Agents; Urinary Bladder Neoplasms | 2004 |
Photodynamic diagnosis (5-aminolevulinic acid) of transitional cell carcinoma after bacillus Calmette-Guérin immunotherapy and mitomycin C intravesical therapy.
Topics: Administration, Intravesical; Aminolevulinic Acid; Antibiotics, Antineoplastic; BCG Vaccine; Biopsy; Carcinoma, Transitional Cell; Cystoscopy; False Positive Reactions; Female; Humans; Inflammation; Leukocyte Count; Logistic Models; Male; Mitomycin; Neoplasm Staging; Netherlands; Odds Ratio; Predictive Value of Tests; Pyuria; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urine | 2010 |
Would the benefits of hexaminolevulinate fluorescence cystoscopy be eliminated if every patient received postoperative installation of intravesical chemotherapy?
Topics: Aminolevulinic Acid; Antibiotics, Antineoplastic; Cystoscopy; Female; Humans; Male; Mitomycin; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Urinary Bladder Neoplasms | 2013 |
Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
Topics: Aminolevulinic Acid; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; Mitomycin; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Urinary Bladder Neoplasms | 2020 |